Recent Headlines
Within Pharmaceuticals

CannaLicense Partners with KindReviews.com to Help Medical Marijuana Patients Learn About Efficacy and Strains

CannaLicense has just announced that they have partnered with KindReviews.com to help medical marijuana patients learn about efficacy and strains. Cannalicense is a medical marijuana licensing company that works with residents of Colorado and Arizona to get a license, to treat their illnesses and... - August 19, 2011 - CannaLicense

ImpactRx Announces Enhancements to BrandImpact Oncology

Data Capture Expanded to Directly Connect Biomarker Testing to Cancer Treatment - August 18, 2011 - ImpactRx, Inc

Novus Releases New Mix-and-Match Pathway Assay Kits

Novus’ new Mix-and-Match Pathway Assay Kits allow for the simultaneous detection of activation states of multiple kinases in a signal pathway on a single multiwell platform. Their kits are designed to be much easier and faster than traditional Western blots (2.5 hour protocol), demonstrate a... - August 18, 2011 - Novus Biologicals

MoBiTec GmbH, Germany, is Offering Nuclear Receptor Fusion Proteins That Are of Importance to the Pharmaceutical Industry for FRET Interaction Studies

MoBiTec GmbH, Germany, supplier of research tools, introduces a collection of Nuclear Receptor-Ligand Binding Domain fusion proteins, carrying a GST tag, capable to bind a Europium-anti-GST antibody. With this the influence of fluorophore-labeled peptides on the ligand binding characteristics can be studied. E.g. the addition of a particular peptide might prevent the receptor from binding a ligand, thereby eliminating a response of a cell to a given stimulus. - August 17, 2011 - MoBiTec GmbH

Mouse Monoclonal DUX4 Antibody Announced by Novus Biologicals

DUX4 is a transcriptional activator of PITX1, whose expression is epigenetically suppressed in differentiated tissues. DUX4 defects are suspected to cause facioscapulohumeral dystrophy (FSHD), a degenerative skeletal muscle disease and one of the most common muscular dystrophies. In FSHD... - August 17, 2011 - Novus Biologicals

Parameter CEO to Discuss "Two-Temp Method" at NCSL Intl

Humidity control approach provides exceptional uniformity, control - August 17, 2011 - Parameter Generation and Control

AmazonDrops Wants to Present You with Pracaxi and Other Odd Amazonian Treasures

AmazonDrops products - not sold in stores - until recently were only available in doctors and aestheticians' offices. Many companies call themselves organic. Few like AmazonDrops can say they are 100% purely organic with nothing added, no preservative, no chemical, not even water. The botanicals used in AmazonDrops are grown and harvested in the Amazon rainforest. - August 16, 2011 - AmazonDrops Organic Skin Care

Iofina Chemical Appoints Viachem as Exclusive Chloramine-T Marketer

Viachem Will Sell Iofina Chemical’s Chloramine-T for biocidal uses in the Aquaculture Industry and for Hydrotherapeutic Applications. - August 16, 2011 - Viachem, Ltd.

S.L.E. Lupus Foundation Brightens Days for 40 New York City Kids with Lupus and Their Families with Free Week at Camp Sunshine

40 New York City children and teens with lupus and their families converge on Camp Sunshine for Lupus Week hosted by the S.L.E. Lupus Foundation. Located on Lake Sebago in Maine, Camp Sunshine offers the only program in the nation to address the impact of a life-threatening illness on every member of the immediate family. The S.L.E. Lupus Foundation raises private funds to send families selected by eligibility and need to Camp Sunshine each summer. - August 15, 2011 - S.L.E. Lupus Foundation

AnaSpec Offers Monoclonal Antibody, Anti-5-Methylcytidine

AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - August 14, 2011 - AnaSpec, EGT Group

AnaSpec Highlights Calcein AM with High Purity Grades

AnaSpec is pleased to provide Calcein AM at two purity grades, >90% or >95%, as determined by HPLC. AnaSpec also offers the SensoLyte® Calcein Cell Viability Assay Kit - a rapid and sensitive assay to detect viable cells. This kit provides ample reagents (dye and assay buffer) for 1000... - August 14, 2011 - AnaSpec, EGT Group

Professor Attygalle of Stevens Lectures at a Max Planck Institute on Mass Spectrometry

Mass spectrometry expert Dr. Athula Attygalle from Stevens Institute of Technology lectured at a Max Planck Institute in Jena, Germany, earlier this summer. - August 11, 2011 - Stevens Institute of Technology

IAOP Conducting Global Survey: Corporate Social Responsibility in Outsourcing

Results to be released at 2012 Outsourcing World Summit. - August 11, 2011 - IAOP

GenScript Launches Animal Model Services Worldwide

Internationally recognized biology contract research organization GenScript USA Inc. today announced that it has launched a broad spectrum of Animal Model Services for researchers to investigate the efficacy and safety profile of drug candidates. The services include in vivo drug efficacy,... - August 10, 2011 - GenScript USA Inc.

Thirty Regional Companies Selected to Present at the 2011 Rocky Mountain Life Science Investor Conference in Denver

The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO. - August 10, 2011 - Colorado BioScience Association

UNIVEC Announces FDA Labeler Code Approval

UNIVEC announces FDA approval of Labeler Code. Univec, Inc. (UNVC) a specialty pharmaceutical company, announces it has been issued a FDA labeler code. This is the prefix for each National Drug Code (NDC) on products that is manufactured and distributed by Univec for the company’s Specialty... - August 09, 2011 - UNIVEC INC

Bencos Shifts Website Domain from .in to .com

Bencos Research Solutions Pvt. Ltd. is now available at www.bencoslife.com. - August 09, 2011 - Bencos Research Solutions

Trophikos Says Research Supports Cranberry PACs as Key to Promoting Urinary Tract Health

Trophikos says that despite findings from a recent Dutch study, previous studies have shown that cranberry supplements can be effective in promoting urinary tract health if they contain enough proanthocyanidins (PAC). Research demonstrates that 36 mg PAC is key, and the new product ellura meets this standard. - August 05, 2011 - Trophikos, LLC

FDA Supplier Management Conference Chaired by Cerulean's John Avellanet

Cerulean's John Avellanet will chair a three-day conference of FDA officials and industry veterans discussing key regulatory requirements and industry best practices for managing suppliers and conducting supplier qualification. - August 05, 2011 - Cerulean Associates LLC

Noor Pharmaceuticals Launches New Line of Halal Vitamins Just in Time for Ramadan 2011

Taking multivitamins is recommended to maintain general health, especially during long periods of fasts, such as the month of Ramadan. For the first time, Muslims can enjoy scientifically formulated Halal Vitamins thanks to NoorVitamins at www.NoorVitamins.com - August 05, 2011 - Noor Pharmaceuticals

SalesForce4Hire® Releases White Paper on a "Shared Risk – Shared Reward" Sales Model

Leading Custom Sales Solutions Company Addresses Advantages of a Strategic Sales Partner Over Traditional Outsourced Sales Organizations - August 05, 2011 - SalesForce4Hire

SHL to Speak and Exhibit at the World Drug Delivery Congress 2011

SHL will speak and exhibit at the upcoming Drug Delivery Congress in Singapore from September 5-6th. - August 05, 2011 - SHL Group (Scandinavian Health Group Ltd)

Circle City Tickets Announces No Service Fees on Internet Orders

Circle City Tickets, the largest ticket broker in Indiana, continues to be leader in the ticketing industry with it's announcement of "No Fees" on all orders including internet and smart phone orders. - August 04, 2011 - Circle City Tickets

Mitegen Announces Distribution of AP Innovation's Quick Puck Loader

Innovative Tool increases speed and reduces errors during puck loading - August 03, 2011 - MiTeGen, LLC

Colorado Institute for Drug, Device and Diagnostic Development Awards Funding to Flashback Technologies

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has selected Longmont, CO-based Flashback Technologies, Inc. to receive funding and management assistance. - August 03, 2011 - Colorado Institute for Drug, Device and Diagnostic Development

Mouse Monoclonal ABCG8 Antibody Announced by Novus Biologicals

Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody. ABCG8 is an ATP binding cassette family member which acts to exclude non-cholesterol sterol entry to the intestine, to promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into... - August 03, 2011 - Novus Biologicals

AbboMax Announces the Availability of New Mouse Anti-Desmoglein 3 (Dsg3) Monoclonal Antibody

Desmogleins are calcium-binding transmembrane glycoproteins, members of the desmosomal cadherins that provide adhesive integrity to desmosomes between adjoining keratinocytes. Desmoglein 3 protein has been identified as the autoantigen of the autoimmune skin blistering disease pemphigus vulgaris and plays important roles in human squamous cell cancer. - August 03, 2011 - AbboMax, Inc.

BioPharm Systems to Present at the 16th Annual Oracle Health Sciences User Group Meeting

Leading IT consulting company focused on the implementation and hosting of clinical trial software will speak at Oracle's annual event. - August 03, 2011 - BioPharm Systems

Vita-Flora Health Introduces BIO-V™, a New Probiotic Supplement for Women’s Health

Vita-Flora Health today announced the worldwide introduction of BIO-V™, a newly-formulated probiotic supplement for women. BIO-V™ is the only product of its kind to use the BIO-tract® delivery system, which more effectively balances pH and flora in the vagina, essentially... - August 03, 2011 - Vita-Flora Health

Survey Reveals: 77% of Dermatologists Will Prescribe Topical Minocycline. Foamix’s First-in-Class Minocycline Foam - Now in Phase II

Most Dermatologists are concerned with Oral Minocycline side effects and will prefer prescribing their patients Topical Minocycline for Rosacea, Acne, Skin Infections and Chronic Wounds. - August 02, 2011 - Foamix Ltd

Novus Biologicals Announces VMAT2 Antibody Made Using SDIX Genomic Antibodies™

Novus Biologicals announced today a new VMAT2 antibody (NBP1-69750) for use in neurotransmission research. This VMAT2 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). VMAT2 is a multipass membrane protein responsible for vesicular transport of neurotransmitters by pumping... - August 01, 2011 - Novus Biologicals

New Products Now Available Via the NovaTeinBio Website

Boston based biological reagents provider, NovaTeinBio Inc. has recently announced that they have added new products to their varied catalogue. The new products are an addition to the already outstanding array of solutions that the company offers to their clients across the scientific... - July 31, 2011 - Novatein Biosciences

Breakthrough Indentation Yield Strength Test by Nanovea

Nanovea introduced its patent pending breakthrough method of reliably acquiring yield strength through indentation; ultimately replacing the traditional tensile testing machine for yield strength measurement. - July 30, 2011 - NANOVEA

Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says

A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

Enhanced POP 2.0 Provides Custom Insight Into the Physician's Mindset at the Point of Promotion and Prescribing

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announces the rollout of POP 2.0, a proprietary, event-triggered survey tool utilized by the Company's iPhone-enabled longitudinal physician panels. Triggered by events already collected through the... - July 29, 2011 - ImpactRx, Inc

Stevens Professor EH Yang Receives DURIP Grant to Support Nanoscale Imaging

Dr. Yang's AFOSR-sponsored DURIP grant allows him to purchase a scanning probe microscope capable of imaging in ambient conditions. - July 29, 2011 - Stevens Institute of Technology

Dr. Chandramouli of Stevens Gives Keynote on Dynamic Spectrum Access at Wireless Security Conference

Dr. R. Chandramouli of Stevens gave the Wireless Summit track keynote lecture, “Dynamic Spectrum Access Wireless Networking," at the NIKSUN World Wide Security & Mobility Conference 2011 (NIKSUN WWSMC) in Princeton, NJ, on July 27. - July 29, 2011 - Stevens Institute of Technology

Vitiligo Product Company Launches New Website

Supernatural Health, makers of Recouleur®, a patented dietary supplement that supports restoration of skin color in vitiligo, unveils new website - July 28, 2011 - Supernatural Health, Inc.

Colorado Institute for Drug, Device and Diagnostic Development Sets August 5th as Submission Date for New Project Consideration

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) is seeking its fifth project and a review date of Friday, August 5th has been selected as the cut-off for submitting material to CID4.com for consideration. - July 27, 2011 - Colorado Institute for Drug, Device and Diagnostic Development

Exploring Science Through Underwater Robotics

The Center for Innovation in Engineering and Science Education at Stevens is leading a National Science Foundation initiative to improve K-12 STEM skills and education through fun summer camps and educator institutes. - July 27, 2011 - Stevens Institute of Technology

curasan AG Signs Exclusive Sales Agreement with Zimmer Dental Inc., USA

curasan AG, listed in the General Standard of the German Stock Exchange, has signed an agreement which provides Zimmer Dental Inc, Carlsbad, CA, (USA) with exclusive global distribution rights. - July 27, 2011 - curasan AG

Ameridose Vice President of Regulatory Affairs and Compliance Presents at LSHP Annual Meeting

Ameridose, LLC, a leading nationwide provider of sterile admixing services to hospital pharmacies, is honored that Ameridose Vice President of Regulatory Affairs and Compliance, Sophia Pasedis, PharmD, was invited to speak at the 2011 Louisiana Society of Health-System Pharmacists (LSHP) Annual... - July 26, 2011 - Ameridose, LLC

BioRegenerative Sciences, Inc. Releases L-Ease a Stem Cell, Antioxidant-Based Eye Drop for Cataract

The L-Ease eye drops contain a proprietary blend of SRM and antioxidants proven to protect eye tissue against the formation of opacities. - July 26, 2011 - BioRegenerative Sciences, Inc.

Colic Calm Creates Comprehensive Listing of Why Your Baby May be Crying

Finally, moms can turn to one place to see if their baby has colic, and what they can do to help them. - July 22, 2011 - TJL Enterprises

Raybiotech Launches Risk-Free Trial Program for ELISA Kits

RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011 - RayBiotech, Inc

South Portland Call Center Announces Shanna Utgard's One-Year Anniversary

This July, Dr. Newton's Naturals celebrates Shanna Utgard's one-year anniversary with the company. An Inbound Sales Floor Supervisor, Utgard came to Dr. Newton’s with over 5 years of call center Sales and Customer Service experience -- along with advanced trainings under her belt. Previous... - July 22, 2011 - Dr. Newton's Naturals

Imapact Rx Announces New Additions to Management Team

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announces that Rob Delghiaccio has joined ImpactRx as Senior Vice President of Business Development and Jim Cronin was promoted to Senior Vice President, Oncology Franchise. Rob Delghiaccio comes to... - July 22, 2011 - ImpactRx, Inc

Recent Headlines Within Pharmaceuticals

Recent Headlines
Within Pharmaceuticals